NIH-funded research NIH-funded research

How HIV medicines may affect hearing

Official title: Ototoxicity-associated Mutations Following Antiretroviral Exposure

Funded at Portland VA Medical Center · NIH-11306628 · Data updated 2026-11-12

This project tests whether some HIV medications cause mitochondrial changes that lead to hearing loss in people taking antiretroviral therapy.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionPortland VA Medical Center
NIH-funded
Lab location1 site (Portland, United States)
Project startJanuary 1, 2024
Project endDecember 31, 2028
Funding year2026
NIH project number5IK2RX004275-03
Project IDNIH-11306628 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people living with HIV or taking antiretroviral therapy who can provide blood samples and complete hearing evaluations.

Less likely to help

People not exposed to antiretroviral drugs or whose hearing loss is clearly due to other causes (e.g., trauma or long-standing noise exposure) may not receive direct benefit.

What this research studies

You would give a blood sample and have hearing tests so researchers can look for changes in mitochondrial DNA and links to hearing problems. The team will compare mitochondrial genetics and hearing results in people exposed to different antiretroviral drugs and use statistical models to identify risk patterns. The work combines genetic sequencing, audiology measures (like audiograms), and clinical data to find markers tied to drug-related hearing loss. Findings will be used to suggest who might be at higher risk and to design ways to prevent or reduce hearing damage.

Why it matters

Potential benefit: If successful, this work could identify people at higher risk of drug-related hearing loss and help guide safer medication choices or monitoring to protect hearing.

How similar studies have gone: Animal and preclinical studies have suggested HIV drugs can harm hearing, but human studies are limited, so this approach is relatively new in people.

Where this research is happening

  • Portland VA Medical Center
    Portland, United States
    Active

Researchers

  • Principal investigator: Debacker, James Riley — Portland VA Medical Center
  • Study coordinator: Debacker, James Riley

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.